JOURNAL ARTICLE
META-ANALYSIS
REVIEW
SYSTEMATIC REVIEW
Add like
Add dislike
Add to saved papers

Endurance Training and V˙O2max: Role of Maximal Cardiac Output and Oxygen Extraction.

PURPOSE: Although endurance training (ET) commonly augments maximal oxygen consumption (V˙O2max), it remains unclear whether such increase is associated with that of maximal cardiac output (Qmax) alone or along with arteriovenous oxygen difference (a-V˙O2diff). Herein, we sought to systematically review and determine the effects of ET on V˙O2max, Qmax, and a-V˙O2diff at maximal exercise, and on their associations, in healthy young subjects.

METHODS: We conducted a systematic search of MEDLINE, Scopus, and Web of Science (from their inception until September 2014) for articles assessing the effects of ET lasting ≥3 wk on V˙O2max and Qmax and/or a-V˙O2diff at maximal exercise in healthy young adults (mean age <40 yr). Meta-analyses were performed to determine standardized mean differences (SMD) in V˙O2max, Qmax, and a-V˙O2diff at maximal exercise between posttraining and pretraining measurements. Subgroup and meta-regression analyses were used to evaluate associations among SMD and potential moderating factors.

RESULTS: Thirteen studies were included after systematic review, comprising a total of 130 untrained or moderately trained healthy young subjects (mean age, 22-28 yr). Duration of ET programs ranged from 5 to 12.9 wk. After data pooling, V˙O2max (SMD = 0.75, P < 0.0001) and Qmax (SMD = 0.64, P < 0.0001), but not a-V˙O2diff at maximal exercise (SMD = 0.21, P = 0.23), were increased after ET. No significant heterogeneity was detected. With meta-regression, the SMD in Qmax was positively associated with the SMD in V˙O2max (B = 0.91, P = 0.007). The SMD in a-V˙O2diff at maximal exercise was not associated with the SMD in V˙O2max (B = 0.20, P = 0.40).

CONCLUSIONS: Based on a relatively small number of studies, improvement in V˙O2max following 5-13 wk of ET is associated with increase in Qmax, but not in a-V˙O2diff, in previously untrained to moderately trained healthy young individuals.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app